Lv3
250 积分 2022-06-29 加入
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
12天前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
13天前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
16天前
已完结
1075 HBM1020 is a fully human novel anti-B7H7 antibody with excellent preclinical efficacy and safety profile
29天前
已关闭
A novel oral hPTH(1-34) unveils the promise of modeling-based anabolism with no increase in bone remodeling
1个月前
已完结
1065 ROR2-targeted T-cell engager as a novel therapeutic approach in solid tumor
1个月前
已完结
Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells
2个月前
已完结
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas
2个月前
已完结
Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma
2个月前
已完结
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor
2个月前
已完结
皖公网安备34019202002308
